Source 1review2024Current Pharmaceutical Design
Toolkit/gene therapy
gene therapy
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Furthermore, it highlights the integration of advanced therapeutic technologies such as gene therapy, optogenetics, and neurostimulation techniques.
Usefulness & Problems
Why this is useful
The review presents gene therapy as an advanced therapeutic technology for neurological disorders. It is framed as a way to restore neuronal function and potentially modify disease.; advanced therapeutic intervention for neurological disorders; restoration of neuronal function; potential disease modification
Source:
The review presents gene therapy as an advanced therapeutic technology for neurological disorders. It is framed as a way to restore neuronal function and potentially modify disease.
Source:
advanced therapeutic intervention for neurological disorders
Source:
restoration of neuronal function
Source:
potential disease modification
Problem solved
It addresses the need for more precise and potentially disease-modifying interventions in neurological disorders. The review positions it as going beyond standard symptomatic pharmaceutical treatment.; enables targeted therapeutic modulation beyond conventional pharmaceutical intervention
Source:
It addresses the need for more precise and potentially disease-modifying interventions in neurological disorders. The review positions it as going beyond standard symptomatic pharmaceutical treatment.
Source:
enables targeted therapeutic modulation beyond conventional pharmaceutical intervention
Problem links
enables targeted therapeutic modulation beyond conventional pharmaceutical intervention
LiteratureIt addresses the need for more precise and potentially disease-modifying interventions in neurological disorders. The review positions it as going beyond standard symptomatic pharmaceutical treatment.
Source:
It addresses the need for more precise and potentially disease-modifying interventions in neurological disorders. The review positions it as going beyond standard symptomatic pharmaceutical treatment.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
No technique tags yet.
Target processes
diagnosticInput: Light
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenimplementation constraint: spectral hardware requirementoperating role: sensor
The abstract does not specify vectors or payload formats, but it does state that optimization of drug delivery methods remains a challenge. It also implies a need for suitable targets and diagnostic support.; requires effective drug or payload delivery methods; depends on suitable therapeutic targets and improved diagnostics
The abstract does not show that gene therapy alone solves diagnostic limitations or delivery bottlenecks. It explicitly notes that improved diagnostics, new targets, and optimized delivery are still needed.; the review notes ongoing need for optimization of drug delivery methods; the review notes need for identification of new targets for intervention
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Despite recent advances, neurological disorder treatment still faces challenges including the need for improved diagnostic tools, identification of new intervention targets, and optimization of drug delivery methods.
The review covers recent innovations in neurological disorder treatment including novel therapeutic targets, innovative drug delivery systems, personalized medicine, gene therapy, optogenetics, and neurostimulation.
Gene therapy, optogenetics, and neurostimulation techniques are described as holding promise for precise modulation of neural circuits, restoration of neuronal function, and possible disease modification in neurological disorders.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug gene-therapy
Furthermore, it highlights the integration of advanced therapeutic technologies such as gene therapy, optogenetics, and neurostimulation techniques.
Source:
field challengesupports
Despite recent advances, neurological disorder treatment still faces challenges including the need for improved diagnostic tools, identification of new intervention targets, and optimization of drug delivery methods.
Source:
review scopesupports
The review covers recent innovations in neurological disorder treatment including novel therapeutic targets, innovative drug delivery systems, personalized medicine, gene therapy, optogenetics, and neurostimulation.
Source:
therapeutic promisesupports
Gene therapy, optogenetics, and neurostimulation techniques are described as holding promise for precise modulation of neural circuits, restoration of neuronal function, and possible disease modification in neurological disorders.
Source:
Comparisons
Source-stated alternatives
The review places gene therapy alongside optogenetics, neurostimulation techniques, pharmaceutical interventions, innovative drug delivery systems, and personalized medicine approaches.
Source:
The review places gene therapy alongside optogenetics, neurostimulation techniques, pharmaceutical interventions, innovative drug delivery systems, and personalized medicine approaches.
Source-backed strengths
highlighted as an advanced therapeutic technology with promise for restoration of neuronal function; described as holding promise for disease modification
Source:
highlighted as an advanced therapeutic technology with promise for restoration of neuronal function
Source:
described as holding promise for disease modification
Compared with optogenetic functional interrogation
The review places gene therapy alongside optogenetics, neurostimulation techniques, pharmaceutical interventions, innovative drug delivery systems, and personalized medicine approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: highlighted as an advanced therapeutic technology with promise for restoration of neuronal function; described as holding promise for disease modification.
Relative tradeoffs: the review notes ongoing need for optimization of drug delivery methods; the review notes need for identification of new targets for intervention.
Source:
The review places gene therapy alongside optogenetics, neurostimulation techniques, pharmaceutical interventions, innovative drug delivery systems, and personalized medicine approaches.
Compared with optogenetic membrane potential perturbation
The review places gene therapy alongside optogenetics, neurostimulation techniques, pharmaceutical interventions, innovative drug delivery systems, and personalized medicine approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: highlighted as an advanced therapeutic technology with promise for restoration of neuronal function; described as holding promise for disease modification.
Relative tradeoffs: the review notes ongoing need for optimization of drug delivery methods; the review notes need for identification of new targets for intervention.
Source:
The review places gene therapy alongside optogenetics, neurostimulation techniques, pharmaceutical interventions, innovative drug delivery systems, and personalized medicine approaches.
Ranked Citations
- 1.